0.6315
price up icon6.60%   0.0391
 
loading
전일 마감가:
$0.5924
열려 있는:
$0.595
하루 거래량:
1.60M
Relative Volume:
0.50
시가총액:
$102.19M
수익:
$400.57M
순이익/손실:
$9.21M
주가수익비율:
15.79
EPS:
0.04
순현금흐름:
$146.36M
1주 성능:
+1.84%
1개월 성능:
-32.83%
6개월 성능:
-82.06%
1년 성능:
-89.53%
1일 변동 폭
Value
$0.5947
$0.6466
1주일 범위
Value
$0.55
$0.67
52주 변동 폭
Value
$0.5271
$7.105

아이언우드 제약 Stock (IRWD) Company Profile

Name
명칭
Ironwood Pharmaceuticals Inc
Name
전화
617-621-7722
Name
주소
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Name
직원
253
Name
트위터
@ironwoodpharma
Name
다음 수익 날짜
2025-02-21
Name
최신 SEC 제출 서류
Name
IRWD's Discussions on Twitter

IRWD을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
IRWD
Ironwood Pharmaceuticals Inc
0.6315 100.34M 400.57M 9.21M 146.36M 0.04
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
11.33 49.79B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
167.14 72.11B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.76 4.24M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.80 45.01B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.53 19.43B 16.54B -1.64B 749.00M -1.45

아이언우드 제약 Stock (IRWD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-15 다운그레이드 Jefferies Buy → Hold
2025-04-15 다운그레이드 Wells Fargo Overweight → Equal Weight
2025-04-14 다운그레이드 Citizens JMP Mkt Outperform → Mkt Perform
2024-09-09 개시 Leerink Partners Market Perform
2024-08-08 다운그레이드 CapitalOne Overweight → Equal Weight
2024-01-17 개시 Craig Hallum Buy
2023-12-14 개시 Wells Fargo Overweight
2023-11-09 개시 Jefferies Buy
2023-09-28 개시 JMP Securities Mkt Outperform
2022-09-02 개시 CapitalOne Overweight
2022-04-22 개시 Piper Sandler Overweight
2020-09-30 다운그레이드 Wells Fargo Overweight → Equal Weight
2020-06-17 개시 Northland Capital Outperform
2019-07-10 재개 Credit Suisse Neutral
2019-03-27 업그레이드 Morgan Stanley Underweight → Equal-Weight
2019-02-25 업그레이드 H.C. Wainwright Sell → Neutral
2019-01-24 업그레이드 JP Morgan Underweight → Neutral
2018-11-07 다운그레이드 Credit Suisse Outperform → Neutral
2018-11-07 다운그레이드 JP Morgan Neutral → Underweight
2018-07-23 개시 H.C. Wainwright Sell
2018-05-09 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2018-01-05 다운그레이드 BofA/Merrill Buy → Underperform
2017-12-06 다운그레이드 Mizuho Buy → Neutral
2017-07-21 다운그레이드 JP Morgan Overweight → Neutral
2017-05-03 개시 Wells Fargo Outperform
2017-04-07 재확인 Mizuho Buy
2017-02-22 재확인 Barclays Equal Weight
2016-11-04 재확인 Mizuho Buy
2016-10-24 재확인 Wedbush Neutral
2016-10-10 재확인 Mizuho Buy
2016-09-27 재확인 WallachBeth Hold
모두보기

아이언우드 제약 주식(IRWD)의 최신 뉴스

pulisher
May 20, 2025

Ironwood Pharmaceuticals’ chief commercial officer sells $1,486 in stock By Investing.com - Investing.com Canada

May 20, 2025
pulisher
May 20, 2025

Ironwood Pharmaceuticals’ chief commercial officer sells $1,486 in stock - Investing.com Australia

May 20, 2025
pulisher
May 19, 2025

IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates - MSN

May 19, 2025
pulisher
May 16, 2025

Drug developer stocks fall as companies navigate clinical roadblocks - BioWorld MedTech

May 16, 2025
pulisher
May 10, 2025

Ironwood Pharma Stock Draws Retail Investor Ire With Big Q1 Miss And No Earnings Call - MSN

May 10, 2025
pulisher
May 09, 2025

Brokerages Set Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Target Price at $4.78 - Defense World

May 09, 2025
pulisher
May 08, 2025

Pacer Advisors, Inc. Reduces Stake in Ironwood Pharmaceuticals Inc. - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Pacer Advisors, Inc. Expands Stake in Ironwood Pharmaceuticals Inc. - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Ironwood: Q1 Earnings Snapshot - New Haven Register

May 08, 2025
pulisher
May 07, 2025

Ironwood at The Citizens JMP Life Sciences Conference: Strategic Outlook By Investing.com - Investing.com India

May 07, 2025
pulisher
May 07, 2025

Ironwood at The Citizens JMP Life Sciences Conference: Strategic Outlook - Investing.com

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals (IRWD) Maintains LINZESS Sales Outlook Amid Pricing Challenges | IRWD Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Ironwood (IRWD) Reports Q1 Revenue Shortfall, Ending Quarter with Increased Cash Reserves | IRWD Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals (IRWD) Reports Q1 Loss, Misses Revenue Estimates - Nasdaq

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals Q1 2025 Earnings: EPS of -$0.23 Misses Estimate, Revenue Falls Short at $41.14 Million - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals Reports First Quarter 2025 Results | IRWD Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals Reports First Quarter 2025 Results - Business Wire

May 07, 2025
pulisher
May 07, 2025

Ironwood Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 07, 2025
pulisher
May 01, 2025

Analysts Estimate Ironwood Pharmaceuticals (IRWD) to Report a Decline in Earnings: What to Look Out for - Yahoo

May 01, 2025
pulisher
Apr 30, 2025

Ironwood Pharmaceuticals to Participate in The Citizens Life Sci - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference | IRWD Stock News - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference - Business Wire

Apr 30, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals (IRWD) Boosts Earnings Outlook for 2025 - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals (IRWD) Boosts FY25 EBITDA Forecast Amid Strong Demand | IRWD Stock News - GuruFocus

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals hikes adjusted EBITDA guidance to greater than $105M, shares rise - MSN

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance - ADVFN

Apr 25, 2025
pulisher
Apr 25, 2025

Ironwood Pharmaceuticals Reiterates Full-Year 2025 Guidance and Raises Adjusted EBITDA - TradingView

Apr 25, 2025
pulisher
Apr 23, 2025

Ironwood Pharmaceuticals to Present Real-World Data at Digestive - GuruFocus

Apr 23, 2025
pulisher
Apr 22, 2025

Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support - itemonline.com

Apr 22, 2025
pulisher
Apr 18, 2025

Ironwood looks for strategic options after regulatory hurdle for lead drug - MSN

Apr 18, 2025
pulisher
Apr 18, 2025

Ironwood Pharmaceuticals to Explore Strategic Alternatives to Maximize Value for Stockholders - marketscreener.com

Apr 18, 2025
pulisher
Apr 17, 2025

Why Ironwood Pharmaceuticals Inc. (IRWD) Went Down On Thursday? - MSN

Apr 17, 2025
pulisher
Apr 16, 2025

Ironwood Shares Tank on Regulatory Update for Apraglutide - MSN

Apr 16, 2025
pulisher
Apr 16, 2025

Ironwood Pharmaceuticals (IRWD) Faces Setback After FDA Request - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

Ironwood Pharmaceuticals (IRWD) Faces Downgrade and Challenges A - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

Ironwood Pharmaceuticals (IRWD) Faces Downgrade and Challenges Amid FDA Trial Delay | IRWD Stock News - GuruFocus

Apr 16, 2025
pulisher
Apr 15, 2025

Ironwood downgraded at Jefferies on apraglutide-related challenges - MSN

Apr 15, 2025
pulisher
Apr 15, 2025

Jefferies Downgrades Ironwood Pharmaceuticals (IRWD) - MSN

Apr 15, 2025
pulisher
Apr 15, 2025

Wells Fargo Downgrades Ironwood Pharmaceuticals (IRWD) - MSN

Apr 15, 2025
pulisher
Apr 15, 2025

Ironwood's Strategy Shake-Up Raises Eyebrows As Shares Tumble - Finimize

Apr 15, 2025
pulisher
Apr 15, 2025

Ironwood downgraded at Jefferies on apraglutide-related challenges (IRWD:NASDAQ) - Seeking Alpha

Apr 15, 2025
pulisher
Apr 15, 2025

This General Motors Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga

Apr 15, 2025

아이언우드 제약 (IRWD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$8.83
price up icon 2.79%
drug_manufacturers_specialty_generic HCM
$13.86
price up icon 4.76%
$123.66
price up icon 0.51%
drug_manufacturers_specialty_generic RDY
$14.75
price up icon 1.30%
$320.37
price up icon 1.50%
$17.53
price down icon 3.42%
자본화:     |  볼륨(24시간):